Merck KGaA to acquire Exelead Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization for approximately$780 million in cash.Read More
FDA authorizes Pfizer's COVID-19 pill The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for nirmatrelvir and ritonavir tablets (which are co-packaged for oral use and sold under the brand name Paxlovid) for the treatment of mild to moderate COVID-19 in adults and pediatric patients (age 12 and older) who have tested positive for SARS-CoV-2 and who are at high risk of developing severe COVID-19, including hospitalization or death.Read More
Novavax receives CMA from European Commission Novavax announced that the European Commission has granted the company a conditional marketing authorization (CMA) for its Nuvaxovid COVID-19 vaccine for use in individuals age 18 and older. The CMA is applicable in all 27 European Union member states.Read More
FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16-, 17-year-olds The U.S. Food and Drug Administration (FDA) has amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. Specifically, the FDA authorized the use of a single booster dose for administration to individuals 16 and 17 years of age at least six months after completion of primary vaccination with the Pfizer-BioNTech COVID-19 vaccine.Read More
COVID-19-related sales remain strong for lab tool firms in 2021 Laboratory tool companies have been among the biggest beneficiaries of U.S. government COVID-19-related spending on coronavirus testing and vaccine R&D and manufacturing. COVID-19-related sales have propelled sales at Thermo Fisher Scientific, Danaher, and PerkinElmer, already three of the world's largest scientific instrument and reagent providers.Read More